Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay - Test2 - elhamkhani - TriplyDB

Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay

Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay

http://www.wikidata.org/entity/Q24535105

about

HIV/AIDS epidemiology, pathogenesis, prevention, and treatment Use of phylogenetics in the molecular epidemiology and evolutionary studies of viral infections.Advances in developing HIV-1 viral load assays for resource-limited settings Monitoring virologic responses to antiretroviral therapy in HIV-infected adults in Kenya: evaluation of a low-cost viral load assay HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays Detection of HIV-1 p24 Gag in plasma by a nanoparticle-based bio-barcode-amplification method.Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay.Diagnostic accuracy of ultrasensitive heat-denatured HIV-1 p24 antigen in non-B subtypes in Kampala, Uganda Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burden Two types of nanoparticle-based bio-barcode amplification assays to detect HIV-1 p24 antigen.Can HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource-limited settings?Role of the laboratory in ensuring global access to ARV treatment for HIV-infected children: consensus statement on the performance of laboratory assays for early infant diagnosis.Detection of HIV-1 p24 antigen in patients with varying degrees of viremia using an ELISA with a photochemical signal amplification system.Increased Sensitivity of HIV-1 p24 ELISA Using a Photochemical Signal Amplification System.Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring.Monocytes but Not Lymphocytes Carrying HIV-1 on Their Surface Transmit Infection to Human Tissue Ex Vivo.Comparative evaluation of the ExaVir Load version 3 reverse transcriptase assay for measurement of human immunodeficiency virus type 1 plasma load.Assessment of the low-cost Cavidi ExaVir Load assay for monitoring HIV viral load in pediatric and adult patients.The performance of reverse transcriptase assay for the estimation of the plasma viral load in HIV-1 and HIV-2 infections.Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions.Assessment of the Cavidi ExaVir Load Assay for Monitoring Plasma Viral Load in HIV-2-Infected Patients.Introduction to a Special Issue of the Journal of Immunological Methods: Building global resource programs to support HIV/AIDS clinical trial studies.The importance of caregivers in the outcome of pediatric HIV management, Mombasa, Kenya.A model for reduced HIV-1 viral load monitoring in resource-limited settings.HIV viral load monitoring in resource-limited regions: optional or necessary?

P2860

Q30356074-78FB19E3-9A8F-4EF8-AB4C-7F4836E39B23 Q30387664-B94CDA5E-D5A5-4719-8488-88604C482E3B Q30473238-E912510D-6CA0-43DB-AE80-781A7DBE4254 Q33497943-3685AAB1-EFAF-427F-AEED-4B3A6E563202 Q33636945-83DF19CF-4C00-452B-A58A-BCE264F15F89 Q33652072-4861117C-CEF7-46DD-B9BE-36BA1E706A06 Q34514881-F1471A5B-3837-44F4-9C5D-D5CCC641190C Q35678689-D00E1F77-39FB-45F2-AB99-0951CA9A41AC Q35690718-A0225DE6-9014-466F-8A73-C1E37BBED4FF Q36394635-6BA91996-32B5-4F2E-8F6D-78ADED8FEB89 Q36526686-E74082ED-30D2-4AFC-A7AC-28F38F48E1F6 Q36914872-897E3AB6-6D9C-411F-B568-FB0C86D7C91D Q37067960-FAF0DD72-F794-412F-AF87-72A9B28BDF40 Q37140373-3F9574B3-F3DC-4852-8D27-0A6E71ABDFE3 Q37333664-B5993F8F-3147-4658-A163-FC4A7F5AD82D Q37347339-6A95F550-D6D2-4844-875A-31703820558C Q37374897-40E2A2E5-F92E-42EC-8FE0-CA753C1B38A9 Q37441641-15D98720-5CBD-4DBC-889E-494BB537801D Q38384495-62F3C651-941E-4247-BDBA-BF0548A822E9 Q38790676-FE0838C2-4FFF-467B-9AEC-665CC250FD01 Q40197811-5CD8A48E-7F35-4279-AAA8-DDB3619C65ED Q41941058-88467D58-14EA-4F18-9194-9F320A764190 Q42265058-74A70728-E9EA-4E37-8281-3018C1261F8C Q44265409-75830CAF-D316-4D57-8DF6-564F7772F925 Q44629379-EED4B2F4-0132-4422-81DA-60E70E2B0B1E

P2860

Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay

http://www.wikidata.org/entity/Q24535105

description

2005 nî lūn-bûn

@nan

2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Comparison of two human immuno ...... to the standard HIV RNA assay

@ast

Comparison of two human immuno ...... to the standard HIV RNA assay

@en

Comparison of two human immuno ...... to the standard HIV RNA assay

@en-gb

Comparison of two human immuno ...... to the standard HIV RNA assay

@nl

type

label

Comparison of two human immuno ...... to the standard HIV RNA assay

@ast

Comparison of two human immuno ...... to the standard HIV RNA assay

@en

Comparison of two human immuno ...... to the standard HIV RNA assay

@en-gb

Comparison of two human immuno ...... to the standard HIV RNA assay

@nl

prefLabel

Comparison of two human immuno ...... to the standard HIV RNA assay

@ast

Comparison of two human immuno ...... to the standard HIV RNA assay

@en

Comparison of two human immuno ...... to the standard HIV RNA assay

@en-gb

Comparison of two human immuno ...... to the standard HIV RNA assay

@nl

P1433

Q24535105-F6A0BAA6-3EA4-408C-9D5C-05B3A132C15F

P1476

Q24535105-06CB9AC4-291F-4C3A-A6AE-01244E495923

P2093

Q24535105-06D25FF9-6669-4848-A869-552E97D59D1C

Q24535105-14033330-C70E-42A5-AFA1-7B8F1E78F936

Q24535105-34BE0205-7753-4AF4-B0F0-0D90BDD3D19D

Q24535105-4F242273-7D36-4A73-AF72-B0B6FFF35547

Q24535105-570ECAA4-B622-43C3-A040-ABCAAB0812E7

Q24535105-6021669B-BEF4-4FF4-8627-E435A89DA19A

Q24535105-6CC7B87E-8029-4AB6-BB13-1F2F5A0395F7

Q24535105-895AC9F5-A715-4F12-BE64-6139CF66CBC2

Q24535105-9BFA1EF6-9D4D-4586-A080-27510AA32886

Q24535105-A02E19F2-1584-4A6A-BA36-7E1EB46DE904

P2860

Q24535105-0A51F200-4228-4525-AD80-B2122F7754CC

Q24535105-0FE7734E-FCD1-4A26-AA8A-EDEDC210B711

Q24535105-2169D92C-F20B-4FF3-AF39-20E69FCDFE0D

Q24535105-2E2A62C4-843B-4190-BC53-955EDAE7B11F

Q24535105-3029C98E-0921-40C5-9015-7E16D50C3235

Q24535105-36248001-382A-4ADC-8729-F0FBC25109A6

Q24535105-39E6DB53-3DFC-4993-BD76-24A48EE95311

Q24535105-45F0901E-33D7-4FDC-9DD0-CC7C26F9B954

Q24535105-45F245E8-395E-46C5-A456-C379CC814722

Q24535105-52854E6F-B126-4BAA-9561-C20868EF8E44

P304

Q24535105-9E59C941-5E63-4693-A4AF-9228AC0A7E61

P31

Q24535105-81804BEE-D552-4433-943B-DD5ACFFC26F4

P356

Q24535105-BBFF06A4-C01D-4683-9F25-699046E5D3F2

P407

Q24535105-C2385E2D-66D1-4A14-84A3-F99FEA4255BC

P433

Q24535105-40547155-8AC7-447F-B661-B756F888F3F5

P478

Q24535105-36D6A4E7-22DD-49A1-9BCE-E2616EC10A29

P577

Q24535105-C7A77D55-3039-4D29-8891-0D6151417A56

P698

Q24535105-8AA0E824-7D8F-4B11-A9AF-8F1A3C5569F0

P921

Q24535105-2168F6B0-CD8B-4A4D-BF55-61CC6D1069BC

P932

Q24535105-19108D90-957D-41D5-BDCD-E556F0F33681

P356

JCM.43.12.5950-5956.2005

P1433

Journal of Clinical Microbiology

P1476

Comparison of two human immuno ...... to the standard HIV RNA assay

@en

P2093

Ada Cachafeiro

http://www.w3.org/2001/XMLSchema#string

Aleksandra D Danilovic

http://www.w3.org/2001/XMLSchema#string

Cheryl Jennings

http://www.w3.org/2001/XMLSchema#string

Donald J Brambilla

http://www.w3.org/2001/XMLSchema#string

Gary E Corrigan

http://www.w3.org/2001/XMLSchema#string

J Simon Gronowitz

http://www.w3.org/2001/XMLSchema#string

James W Bremer

http://www.w3.org/2001/XMLSchema#string

Jorg Schupbach

http://www.w3.org/2001/XMLSchema#string

Michael A Ussery

http://www.w3.org/2001/XMLSchema#string

Oliviero E Varnier

http://www.w3.org/2001/XMLSchema#string

P2860

A colorimetric reverse transcriptase assay optimized for Moloney murine leukemia virus, and its use for characterization of reverse transcriptases of unknown identity.

Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa.

Comparison of an assay using signal amplification of the heat-dissociated p24 antigen with the Roche Monitor human immunodeficiency virus RNA assay.

Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma.

Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS

Evaluation of a low cost reverse transcriptase assay for plasma HIV-1 viral load monitoring.

Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma.

Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.

p24 Antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection.

Monitoring of human immunodeficiency virus infection in resource-constrained countries.

P304

5950-5956

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.43.12.5950-5956.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16333081

http://www.w3.org/2001/XMLSchema#string

P921

P932

1317157

http://www.w3.org/2001/XMLSchema#string